Ekso Bionics Holdings, Inc.
EKSO
$4.63
-$0.10-2.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.43M | -11.09M | -10.79M | -11.33M | -11.13M |
| Total Depreciation and Amortization | 1.52M | 1.56M | 1.58M | 1.61M | 1.64M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 582.00K | 157.00K | 1.69M | 2.40M | 1.08M |
| Change in Net Operating Assets | -571.00K | 249.00K | -823.00K | -2.53M | -1.58M |
| Cash from Operations | -8.90M | -9.12M | -8.35M | -9.85M | -10.00M |
| Capital Expenditure | -83.00K | -79.00K | -39.00K | -37.00K | -59.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -83.00K | -79.00K | -39.00K | -37.00K | -59.00K |
| Total Debt Issued | 1.92M | -- | -- | -- | -- |
| Total Debt Repaid | -3.25M | -1.25M | -1.25M | -1.25M | -1.25M |
| Issuance of Common Stock | 4.77M | 9.77M | 8.89M | 9.02M | 9.68M |
| Repurchase of Common Stock | -50.00K | -2.00K | -2.00K | -2.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.39M | 8.52M | 7.64M | 7.77M | 8.43M |
| Foreign Exchange rate Adjustments | 22.00K | 33.00K | -2.00K | -31.00K | -20.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.57M | -643.00K | -745.00K | -2.15M | -1.65M |